Community-based Precise Management for Patients With Coronary Artery Disease
- Conditions
- Coronary Artery Disease
- Interventions
- Other: Community-based precise managementOther: Standard community-based management
- Registration Number
- NCT05344053
- Lead Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Brief Summary
The community-based precise management for patients with coronary artery disease study is a prospective, cluster-randomized, open-labeled trial. The purpose of this trial is to test whether a community-based precise management and rehabilitation model under the hierarchical medical system could help improve the cardiovascular risk factors control in patients with coronary artery disease. Additionally, the trial will also evaluate the impact of the model on major cardiovascular adverse events in patients with coronary artery disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 480
- Patients with prior myocardial infarction
- or receiving percutaneous coronary intervention or coronary artery bypass graft;
- or coronary artery stenosis≥50% defined by coronary angiography or coronary CT angiography
- Refuse to sign the written informed consent;
- Patients without the ability to take care of themselves;
- Mental disorders;
- Alcoholics or drug addicts;
- Cannot be followed up for any reasons;
- Life expectancy<1 year due to non-cardiovascular reasons.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Community-based precise management Community-based precise management - Standard community-based management Standard community-based management -
- Primary Outcome Measures
Name Time Method Status of risk factors control of coronary artery disease 1 year A composite of not smoking, blood pressure\<140/90mmHg/\<130/80mmHg for patients with diabetes, HbA1c≤7%, LDL-C\<1.8mmol/L, antiplatelet therapy, and statins use.
- Secondary Outcome Measures
Name Time Method All-cause death 1 year Myocardial infarction 1 year Readmission 1 year Coronary revascularization 1 year Stroke 1 year
Trial Locations
- Locations (1)
Infirmary of Industrial and Commercial Bank of China
🇨🇳Beijing, Beijing, China